TSRO Key Stats
SA Breaking News03/02 17:15
SA Breaking News02/20 09:26
|02/19/2015 16:15 EST||Misc||Tesaro Inc Fourth Quarter Earnings Conference Call in 2014|
|02/19/2015||Earnings||Tesaro Inc Fourth Quarter Earnings in 2014 Release|
|11/05/2014 16:15 EST||Misc||ESARO Inc. Third Quarter Financial Results Conference Call|
|11/05/2014||Earnings||Tesaro to Announce Third-quarter 2014 Financial Results on November 5, 2014|
|07/24/2014 16:15 EDT||Misc||Tesaro Inc Q2 2014 Earnings Conference Call|
|07/24/2014||Earnings||Tesaro Inc Q2 2014 Earnings Results|
|05/16/2014||Misc||Annual General Meeting for Tesaro Inc|
|04/30/2014 16:15 EDT||Misc||Tesaro Inc Q1 2014 Earnings Conference Call|
|04/30/2014||Earnings||Tesaro Inc Q1 2014 Earnings Results|
TSRO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Tesaro is up 56.69% over the last year vs S&P 500 Total Return up 14.31%, Agios Pharmaceuticals up 246.1%, and PTC Therapeutics up 108.1%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for TSRO
PDF Report for TSRO
Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download TSRO Pro Report PDF
Portfolio Strategies Featuring TSRO
Did Tesaro make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.tesarobio.com
- IR Website: http://ir.tesarobio.com/
- HQ Country: United States
- HQ State/Province: Massachusetts
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: December 31, 2015
- Last Fiscal Quarter End: December 31, 2014
- Last Fiscal Year End: December 31, 2014
- Next Earnings Release: N/A
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Tesaro Inc is an oncology-focused biopharmaceutical company engaged in improving the lives of cancer patients. The Company is developing three clinical-stage product candidates including rolapitant, niraparib and TSR-011.
TSRO Excel Add-In Codes
- Name: =YCI("TSRO","name")
- Description: =YCI("TSRO","description")
- Sector: =YCI("TSRO","sector")
- Industry: =YCI("TSRO","industry")
- Est. Current Fiscal Year End: =YCI("TSRO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.